Moderna raises $2.6B to support cancer work; FDA clears updated COVID vaccines

COVID vaccine (updated)Positive

AI Analysis

Summary

Moderna raised $2.6B through an upsized note offering to support cancer research and received FDA clearance for updated COVID vaccines. The capital raise followed positive results from a significant clinical study.

Importance:7/10

Sentiment:

0.70

capital_raiseoncologyCOVID-19FDA_clearancevaccine

Related Companies

$MRNA

Read the original article

Published by BioPharma Dive on August 28, 2026 3:59 PM

Read Original